N-TERMINAL PROPEPTIDE OF COLLAGEN TYPE III AS A PROPOSED MARKER OF MYOCARDIAL FIBROSIS IN TYPE 2 DIABETES
Aim. To evaluate the role of N-terminal procollagen type III propeptide (P3NP) as a proposed marker of myocardial fibrosis in type 2 diabetes (DM2) patients.Material and methods. In the study, 2 groups of patients participated: with DM2 and non-DM2 (both n=32). All patients underwent clinical and la...
Main Authors: | O. M. Drapkina, B. B. Gegenava |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2018-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/831 |
Similar Items
-
High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases
by: Monika Gudowska, et al.
Published: (2017-09-01) -
Serum level of N-terminal propeptide of type I procollagen in people of various ages and gender
by: V.V. Povoroznyuk, et al.
Published: (2020-02-01) -
Levels of bone turnover markers (N-terminal propeptide of type I procollagen and carboxy-terminal telopeptide of type I collagen) in Ukrainian population of different age and gender
by: V.V. Povoroznyuk, et al.
Published: (2020-10-01) -
The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
by: Elma Kučukalić-Selimović, et al.
Published: (2013-11-01) -
Renal ultrasonographic shear-wave elastography and urinary procollagen type III amino-terminal propeptide in chronic kidney disease dogs
by: Chutimon Thanaboonnipat, et al.
Published: (2020-09-01)